4.6 Article

11C-Choline PET/CT and Bladder Cancer Lymph Node Metastasis Assessment With Pathological Specimens as Reference Standard

Journal

CLINICAL NUCLEAR MEDICINE
Volume 40, Issue 2, Pages E124-E128

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/RLU.0000000000000604

Keywords

C-11-choline PET/CT; bladder cancer; pelvic lymph node dissection; lymph node metastasis; radical cystectomy

Ask authors/readers for more resources

Aim: The aim of this study was to evaluate the potential role of C-11-choline-PET/CT in nodal assessment in patients with bladder cancer (BCa) using the pathological specimen as reference standard. Patients and Methods: Fifty-nine patients with proven BCa were retrospectively enrolled from April 2011 to January 2014 (mean [SD] age, 70.1 [9] years; range 49-85 years). Of 59 patients, 39 (staging group) were referred to C-11-choline-PET/CT for preoperative lymph node (LN) evaluation before radical cystectomy and extended pelvic LN dissection. Of the 59 patients, 29 (restaging group) had C-11-choline-PET/CT for suspected BCa relapse after primary radical surgery. In both groups, C-11-choline-PET/CT findings were correlated with histology. Sensitivity, specificity, positive predictive value, negative predictive value, and accuracy were calculated to assess C-11-choline-PET/CT feasibility in LN assessment. Age, TNM, histology, and previous chemotherapy were analyzed as additional predictive factors. Results: C-11-choline-PET/CT overall detection rate was 62.7% (37/59 patients). On a regional-based analysis, C-11-choline-PET/CT was considered positive for primary cancer and/or local relapse in bladder bed in 54.2% of the patients (32/59). Pathological LN uptake was reported in 23.7% of the patients (14/59) and systemic choline deposit (bone or lung) in 11.8% of the patients (7/59). Considering LN metastasis detection, compared with histological analysis, C-11-choline-PET/CT showed in the whole population a sensitivity, specificity, positive predictive value, negative predictive value, and accuracy of 59%, 90%, 71%, 84%, and 81%, respectively. No other investigated factors reached statistical significance. Conclusions: C-11-choline-PET/CT may provide additional diagnostic information in preoperative nodal staging of patients with BCa and be considered a useful tool to restage patients with BCa suspected of relapse. Further studies are needed to assess if C-11'-choline-PET/CT could have an influence on survival of patients with BCa.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Urology & Nephrology

Perioperative Outcomes of Holmium Laser Enucleation of the Prostate: A Systematic Review

Angelo Porreca, Michele Colicchia, Alessandro Tafuri, Daniele D'Agostino, Gian Maria Busetto, Alessandro Crestani, Katia Odorizzi, Nelia Amigoni, Riccardo Rizzetto, Alessandra Gozzo, Sebastian Gallina, Lorenzo Bianchi, Matteo Ferro, Roberto Falabella, Daniele Romagnoli, Alessandro Antonelli, Paolo Corsi, Riccardo Schiavina

Summary: Holmium laser enucleation of the prostate (HoLEP) is a safe procedure with a low overall complication rate. Most reported perioperative complications are not severe, falling into Clavien-Dindo classification grades 1-2. Further randomized studies are necessary to fully understand and prevent surgical complications for continued improvement of this technique.

UROLOGIA INTERNATIONALIS (2022)

Article Urology & Nephrology

Novel Volumetric and Morphological Parameters Derived from Three-dimensional Virtual Modeling to Improve Comprehension of Tumor's Anatomy in Patients with Renal Cancer

Lorenzo Bianchi, Riccardo Schiavina, Barbara Bortolani, Laura Cercenelli, Caterian Gaudiano, Angelo Mottaran, Matteo Droghetti, Francesco Chessa, Sara Boschi, Enrico Molinaroli, Eleonora Balestrazzi, Francesco Costa, Arianna Rustici, Giulia Carpani, Pietro Piazza, Alberta Cappelli, Alessandro Bertaccini, Rita Golfieri, Emanuela Marcelli, Eugenio Brunocilla

Summary: This study evaluated the impact of three-dimensional models on predicting surgical outcomes after robot-assisted partial nephrectomy, finding that certain three-dimensional parameters were significantly associated with surgical complications and operative indicators, providing new possibilities for outcome prediction.

EUROPEAN UROLOGY FOCUS (2022)

Article Urology & Nephrology

Percutaneous ablation or minimally invasive partial nephrectomy for cT1a renal masses? A propensity score-matched analysis

Lorenzo Bianchi, Francesco Chessa, Pietro Piazza, Amelio Ercolino, Angelo Mottaran, Dario Recenti, Carla Serra, Caterina Gaudiano, Alberta Cappelli, Francesco Modestino, Rita Golfieri, Alessandro Bertaccini, Emanuela Marcelli, Angelo Porreca, Antonio Celia, Riccardo Schiavina

Summary: Partial nephrectomy showed higher disease-free survival rates at 5 years compared to local tumor ablation, but overall survival rates were similar. Local tumor ablation had a higher risk of recurrence but lower risk of complications compared to partial nephrectomy.

INTERNATIONAL JOURNAL OF UROLOGY (2022)

Article Urology & Nephrology

Evaluating the performance of clinical and radiological data in predicting prostate cancer in prostate imaging reporting and data system version 2.1 category 3 lesions of the peripheral and the transition zones

Caterina Gaudiano, Lorenzo Bianchi, Beniamino Corcioni, Francesca Giunchi, Riccardo Schiavina, Federica Ciccarese, Lorenzo Braccischi, Arianna Rustici, Michelangelo Fiorentino, Eugenio Brunocilla, Rita Golfieri

Summary: In patients with PIRADSv2.1 3 lesions, multiparametric magnetic resonance imaging (mpMRI) was used to evaluate morphological pattern, diffusion parameters, and vascularisation to predict prostate cancer (PCa). Prostate volume, prostate-specific antigen (PSA) density, lesion zone, and the apparent diffusion coefficient were identified as significant predictors of PCa, with PSA density and lesion zone being independent predictors. Tumors located in the transition zone (TZ) had a greater risk of high-grade disease.

INTERNATIONAL UROLOGY AND NEPHROLOGY (2022)

Article Endocrinology & Metabolism

Long-term outcomes of Holmium laser enucleation of prostate and predictive model for symptom recurrence

Matteo Droghetti, Angelo Porreca, Lorenzo Bianchi, Pietro Piazza, Marco Giampaoli, Carlo Casablanca, Daniele D'Agostino, Giovanni Cochetti, Daniele Romagnoli, Riccardo Schiavina, Eugenio Brunocilla

Summary: Holmium laser enucleation of prostate (HoLEP) shows good long-term outcomes in treating BPH, but an increase in preoperative PVR and IPSS score may be independent predictors for symptom recurrence. Patients with a heavy preoperative symptom burden or high PVR should be carefully counseled on the risk of symptom recurrence.

PROSTATE (2022)

Article Oncology

PARP Inhibitors and Radiometabolic Approaches in Metastatic Castration-Resistant Prostate Cancer: What's Now, What's New, and What's Coming?

Andrea Marchetti, Matteo Rosellini, Giacomo Nuvola, Elisa Tassinari, Veronica Mollica, Alessandro Rizzo, Matteo Santoni, Alessia Cimadamore, Andrea Farolfi, Rodolfo Montironi, Stefano Fanti, Francesco Massari

Summary: Prostate cancer remains a significant health issue in men, with new treatment options such as PARP inhibitors and radiometabolic approaches showing promising clinical benefits. The evolving understanding of molecular characteristics in prostate cancer is expanding treatment possibilities, particularly for patients with altered DNA repair genes. Ongoing clinical trials are focused on further exploring and expanding the use of these treatments in advanced prostate cancer.

CANCERS (2022)

Review Oncology

Radiolabeled Somatostatin Analogues for Diagnosis and Treatment of Neuroendocrine Tumors

Valentina Ambrosini, Lucia Zanoni, Angelina Filice, Giuseppe Lamberti, Giulia Argalia, Emilia Fortunati, Davide Campana, Annibale Versari, Stefano Fanti

Summary: Neuroendocrine neoplasms (NENs) are rare and heterogeneous tumors that require multidisciplinary discussion for optimal care. The theranostic approach plays a crucial role in the management of NENs, but further research is needed to verify its effectiveness.

CANCERS (2022)

Article Chemistry, Multidisciplinary

Prediction of Overall Survival in Cervical Cancer Patients Using PET/CT Radiomic Features

Gianluca Carlini, Nico Curti, Silvia Strolin, Enrico Giampieri, Claudia Sala, Daniele Dall'Olio, Alessandra Merlotti, Stefano Fanti, Daniel Remondini, Cristina Nanni, Lidia Strigari, Gastone Castellani

Summary: Radiomic features can be used to successfully predict survival probability in cervical cancer patients. CT radiomic features proved to be better predictors than PET radiomic features in this specific case.

APPLIED SCIENCES-BASEL (2022)

Article Urology & Nephrology

Percutaneous Ablation Vs Robot-Assisted Partial Nephrectomy for Completely Endophytic Renal Masses: A Multicenter Trifecta Analysis with a Minimum 3-Year Follow-Up

Savio Domenico Pandolfo, Alp T. Beksac, Ithaar Derweesh, Antonio Celia, Riccardo Schiavina, Lorenzo Bianchi, Giovanni Costa, Umberto Carbonara, Davide Loizzo, Giuseppe Lucarelli, Clara Cerrato, Ciro Imbimbo, Vicenzo Mirone, Jeffrey Elbich, Giuseppe Basile, Lance J. Hampton, Fernando J. Kim, Umberto Capitanio, Jihad Kaouk, Riccardo Autorino

Summary: This study compared the outcomes of RAPN and PTA in treating completely endophytic renal masses. The results show that PTA treatment has low complications and good mid-term functional and oncologic outcomes. RAPN is more suitable for younger patients with fewer comorbidities.

JOURNAL OF ENDOUROLOGY (2023)

Article Oncology

The Impact of PSMA-PET on Oncologic Control in Prostate Cancer Patients Who Experienced PSA Persistence or Recurrence

Lorenzo Bianchi, Francesco Ceci, Francesco Costa, Eleonora Balestrazzi, Matteo Droghetti, Pietro Piazza, Alessandro Pissavini, Riccardo Mei, Andrea Farolfi, Paolo Castellucci, Stefano Puliatti, Alessandro Larcher, Giorgio Gandaglia, Daniele Robesti, Alexandre Mottrie, Alberto Briganti, Alessio Giuseppe Morganti, Stefano Fanti, Francesco Montorsi, Riccardo Schiavina, Eugenio Brunocilla

Summary: This study aims to evaluate the oncologic outcomes of patients with recurrent prostate cancer who received PSMA-PET. The results of PSMA-PET had no significant impact on the oncologic outcomes of recurrent prostate cancer patients who never received previous salvage therapies. However, for recurrent prostate cancer patients who had previous salvage therapies, positive PSMA-PET results were associated with worse oncologic outcomes.

CANCERS (2023)

Article Radiology, Nuclear Medicine & Medical Imaging

A novel tool for predicting the dose distribution of non-sealed 188Re (Rhenium) resin in non-melanoma skin cancers (NMSC) patients

Federico Zagni, Sara Vichi, Giulia Paolani, Miriam Santoro, Giuseppe Della Gala, Silvia Strolin, Paolo Castellucci, Luigia Vetrone, Stefano Fanti, Alessio Giuseppe Morganti, Lidia Strigari

Summary: This paper presents a novel Monte Carlo-based tool for calculating the activity and dose of Re-188-based resin. The tool allows personalized calculation of treatment parameters and has been experimentally validated. The results demonstrate the accuracy of the tool in calculating the activity distribution of Re-188 resin.

MEDICAL PHYSICS (2023)

Article Oncology

A Retrospective Multicenter Analysis of the Incidence of Bone-Only Disease at PSMA PET/CT in Castration Resistant Prostate Cancer Patients

Francesca Serani, Wolfgang P. Fendler, Paolo Castellucci, Christoph Berliner, Francesco Barbato, Ken Herrmann, Andrea Farolfi, Stefano Fanti

Summary: This study aimed to determine the incidence of bone-only metastasis in castration-resistant prostate cancer (CRPC) and identify potential predictors of bone-only spread. PSMA PET/CT scans of 179 patients were analyzed, and it was found that 20% of patients had cancer that had spread only to the bones, with the most common sites being the spine, ribs, and hips. Factors such as lymph-node spread at diagnosis and hormone treatment were associated with bone-only spread. These findings highlight the importance of personalized treatment for bone-only disease and the role of PSMA PET scans in accurately detecting prostate cancer.

CANCERS (2023)

Article Oncology

PSMA-PET Guided Treatment in Prostate Cancer Patients with Oligorecurrent Progression after Previous Salvage Treatment

Lorenzo Bianchi, Francesco Ceci, Eleonora Balestrazzi, Francesco Costa, Matteo Droghetti, Pietro Piazza, Alessandro Pissavini, Massimiliano Presutti, Andrea Farolfi, Riccardo Mei, Paolo Castellucci, Giorgio Gandaglia, Alessandro Larcher, Daniele Robesti, Alexandre Mottrie, Alberto Briganti, Alessio Giuseppe Morganti, Stefano Fanti, Francesco Montorsi, Riccardo Schiavina, Eugenio Brunocilla

Summary: In this study, researchers retrospectively analyzed 113 patients with recurrent prostate cancer after radical prostatectomy and salvage therapies. The study found that patients who underwent second-line PSMA-guided metastases-directed therapy (MDT) had better outcomes in terms of metastases-free survival and castration-resistant prostate cancer-free survival compared to those who received conventional management.

CANCERS (2023)

Article Oncology

An Apparent Diffusion Coefficient-Based Machine Learning Model Can Improve Prostate Cancer Detection in the Grey Area of the Prostate Imaging Reporting and Data System Category 3: A Single-Centre Experience

Caterina Gaudiano, Margherita Mottola, Lorenzo Bianchi, Beniamino Corcioni, Lorenzo Braccischi, Makoto Taninokuchi Tomassoni, Arrigo Cattabriga, Maria Adriana Cocozza, Francesca Giunchi, Riccardo Schiavina, Stefano Fanti, Michelangelo Fiorentino, Eugenio Brunocilla, Cristina Mosconi, Alessandro Bevilacqua

Summary: This study explores the role of multiparametric magnetic resonance imaging (mpMRI) as a stand-alone tool for early and non-invasive detection of prostate cancer (PCa) in PI-RADS 3 lesions through radiomic analysis. The results show that mpMRI achieves 80% positive predictive value, 76% specificity, and 78% sensitivity. This study offers a pathway to improve the interpretation of PI-RADS 3 lesions and image-driven PCa diagnosis.

CANCERS (2023)

No Data Available